Offer - Urjas Oil for just ₹ 1 X
Tacrotor 0.1% Ointment, a prescription drug, is manufactured in various forms such as Ointment. Liver transplant, Kidney transplant, Heart Transplant are some of its major therapeutic uses. The alternative uses of Tacrotor 0.1% Ointment have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Tacrotor 0.1% Ointment. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Tacrotor 0.1% Ointment as well, which are listed below. Such side effects of Tacrotor 0.1% Ointment normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Tacrotor 0.1% Ointment is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Tacrotor 0.1% Ointment's effects on the liver, heart and kidney are discussed below in the Tacrotor 0.1% Ointment related warnings section.
Tacrotor 0.1% Ointment is not recommended if you suffer from certain medical conditions as it can have adverse effects. Infections, Diabetes Type 2 are examples of such conditions. Other conditions have been mentioned below in the Tacrotor 0.1% Ointment contraindications section.
Besides this, Tacrotor 0.1% Ointment may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Tacrotor 0.1% Ointment is safe while driving, and is is addictive in nature.
Tacrotor 0.1% Ointment is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Tacrotor 0.1% Ointment safe for pregnant women?
Tacrotor may have some side effects during pregnancy. Pregnant women should discontinue the use of Tacrotor, and talk to their doctor, if they notice any discomfort.
Is the use of Tacrotor 0.1% Ointment safe during breastfeeding?
Tacrotor may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Tacrotor, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Tacrotor.
What is the effect of Tacrotor 0.1% Ointment on the Kidneys?
There can be some harmful effects on your kidneys after taking Tacrotor. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Tacrotor 0.1% Ointment on the Liver?
The liver can be affected by Tacrotor. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Tacrotor only after medical advice.
What is the effect of Tacrotor 0.1% Ointment on the Heart?
There may be severe side effects of Tacrotor on your heart. Do not take it unless a doctor says so.
If you are suffering from any of the following diseases, you should not take Tacrotor 0.1% Ointment unless your doctor advises you to do so -
Is this Tacrotor 0.1% Ointment habit forming or addictive?
No, there is no any evidence that Tacrotor 0.1% Ointment is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Tacrotor 0.1% Ointment will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Tacrotor 0.1% Ointment should be used only after doctor's advice.
Is it able to treat mental disorders?
Tacrotor 0.1% Ointment is unable to treat or cure mental disorders.
Interaction between Food and Tacrotor 0.1% Ointment
There is no information on the effects of taking Tacrotor 0.1% Ointment with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Tacrotor 0.1% Ointment
Consult your doctor before consuming alcohol while taking Tacrotor 0.1% Ointment as it can have severe side effects.
No, you cannot take the Tacrotor with fluconazole, as it may change the effect of the Tacrotor and cause some serious side effects, always consult your doctor before taking this drug combination.
Yes, Tacrotor may cause hair loss. The patients who are taking this drug are at risk of alopecia (hair loss). If you are experiencing the same after taking this drug, you are advised to consult about it with your doctor immediately.
Yes, Tacrotor is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as headache, diarrhea, constipation, nausea, vomiting. If you experience any discomfort after taking this do inform your doctor.
No, you cannot take the Tacrotor with Ibuprofen, as it may change the effect of the Tacrotor and cause some serious side effects, always consult your doctor before taking this drug combination.
Tacrotor is a brand name of tacrolimus and it is available in the form of a capsule, granules for oral suspension, an extended-release tablet, injectables, and ointment. It belongs to the class of drugs known as immunosuppressants. Tacrotor is a prescription drug that is used to prevent the rejection of organ transplants (liver and kidney). The topical form of Tacrotor is used to treat eczema.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167